Heat Biologics Inc

-0.27 (-4.13%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)151.31M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.25 Million
Adjusted EPS-$0.28
See more estimates
10-Day MA$6.72
50-Day MA$7.47
200-Day MA$8.42
See more pivots

Heat Biologics Inc Stock, NASDAQ:HTBX

627 Davis Drive, Suite 400, Morrisville, North Carolina 27560
United States of America
Phone: +1.919.240.7133
Number of Employees: 39


Heat Biologics, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company's T-cell activating platform (TCAP) produces therapies designed to turn immunologically cold tumors to hot, and be administered in combination with checkpoint inhibitors and other immuno-modulators to increase clinical effectiveness. Its TCAP product candidates from the company's ImPACT and ComPACT platforms are produced from allogeneic cell lines expressing tumor-specific proteins common among cancers. The company was founded by Jeffrey Alan Wolf on June 10, 2008 and is headquartered in Morrisville, NC.